Graft-versus-host disease laboratory findings

Graft-versus-host disease
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Graft-versus-host disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
Echocardiograph and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Graft-versus-host disease laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Graft-versus-host disease laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Graft-versus-host disease laboratory findings
CDC on Graft-versus-host disease laboratory findings
Graft-versus-host disease laboratory findings in the news
Blogs on Graft-versus-host disease laboratory findings
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Graft-versus-host disease laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]

Overview

The laboratory findings for GvHD focus on the organs involved.

Laboratory Findings

• Skin: There are no specific laboratory findings for skin GvHD.

• Liver: Laboratory findings include elevated total bilirubin, elevated alkaline phosphatase, elevated gamma-glutamyltransferase (GGT), elevated aspartate aminotransferase (AST), elevated alanine aminotransferase (ALT), low albumin, elevated prothrombin time (PT), elevated partial thromboplastin time (PTT)..

• GI tract: There are no specific laboratory findings for skin GvHD.